HealthVerity IPGE Blog Series: Privacy
In the first installment of our HealthVerity IPGE blog series covering the four foundational...
In the first installment of our HealthVerity IPGE blog series covering the four foundational...
How real-world data (RWD) from open and closed claims and beyond can be layered to better explore...
Patient Identity Resolution: The next era of healthcare data interoperability The HealthVerity...
The intrinsic role of real-world data to help determine the necessity for booster shots as new...
In a recent HealthVerity LIVE webinar, we took an in-depth look at how the HealthVerity IPGE...
COVID-19 urgently highlighted the need for real-time data, and with it, the need to tap into a...
A data-rich longitudinal patient journey is key to research and development, commercialization and...
This post was originally published on the AWS for Industries blog by Jared Saul, Global Head of ...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly changing the landscape of life sciences, offering powerful tools for streamlining clinical trials, optimizing drug development, and enhancing regulatory ...